No doubt, you all have a few patients who don't comply with their diabetes medication regimens, perhaps because they're too complicated. If so, here's news these patients will welcome.

Bristol-Myers Squibb has submitted a regulatory application to the FDA to gain marketing approval for metformin hydrochloride (Glucophage) Extended Release Tablets, to be taken once a day.

This extended-release form was found in a study of 1,200 patients to offer efficacy and safety data equivalent to that of the currently marketed form of the drug, while offering the convenience of once-daily dosing.